These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6525605)

  • 1. Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial.
    Locker GY; Lanzotti V; Sweet D; Lad T; Khandekar J; Stiff P; Johnson C; Miller S
    Cancer Treat Rep; 1984 Oct; 68(10):1303-4. PubMed ID: 6525605
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomas.
    Mischler NE; Tormey DC; Klotz J; Borden EC; Ramirez G; Banerjee TK; Carr RM; Zaentz SD; Graf J
    Cancer Clin Trials; 1981; 4(4):407-10. PubMed ID: 7318122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
    Locker GY; Lanzotti V; Khandekar JD; Sweet D; Shaw J; Bitran J; Gordon L; Krauss S; Johnson C
    Cancer Treat Rep; 1986 Feb; 70(2):307-8. PubMed ID: 3948195
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
    Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
    Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of mitoxantrone in previously untreated patients with colorectal adenocarcinoma: A Southwest Oncology Group Study.
    Cowan JD; Von Hoff DD; McDonald B; Talley RW; McCracken JD; Chen T
    Cancer Treat Rep; 1982 Sep; 66(9):1779-80. PubMed ID: 7116355
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trial of aminothiadiazole in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
    Locker GY; Khandekar J; Krauss S; Reisel H; Hoeltgen T; Wolter J; Haid M; Hoffman R; Blough R; Johnson C
    Cancer Treat Rep; 1987 Jun; 71(6):649-50. PubMed ID: 3555791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancer.
    Schutt AJ; Hahn RG; Moertel CG; O'Connell MJ; Rubin J; Creagan ET
    Cancer Treat Rep; 1983 May; 67(5):505-6. PubMed ID: 6406062
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of esorubicin in patients with advanced colorectal carcinoma and no prior chemotherapy: an Illinois Cancer Council Trial.
    Locker GY; Hoeltgen T; Kilton L; Krauss S; McNamara M; Blough R; Johnson C
    Cancer Treat Rep; 1987; 71(7-8):765-6. PubMed ID: 3300969
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.
    O'Connell MJ; Rubin J; Hahn RG; Kvols LK; Moertel CG
    Cancer Treat Rep; 1987 Mar; 71(3):333-4. PubMed ID: 3815402
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of maytansine in patients with advanced colorectal carcinoma.
    O'Connell MJ; Shani A; Rubin J; Moertel CG
    Cancer Treat Rep; 1978 Aug; 62(8):1237-8. PubMed ID: 356981
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II study of N-methylformamide in patients with advanced colorectal cancer.
    Tchekmedyian NS; Kaplan RS; Eisenberger M; Abrams J; Van Echo D
    Cancer Treat Rep; 1987 May; 71(5):541-2. PubMed ID: 3567980
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II study of 3-deazauridine in advanced colorectal adenocarcinoma.
    Bruno S; Creaven PJ; Ledesma E; Poster D; Yoon J; Mittelman A
    Am J Clin Oncol; 1982 Feb; 5(1):69-71. PubMed ID: 7081140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vindesine in the treatment of advanced colorectal cancer: a phase II study.
    Diaz-Rubio E; Martin-Jimenez M
    Cancer Treat Rep; 1984 Mar; 68(3):555-6. PubMed ID: 6704985
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of hycanthone in patients with advanced colorectal carcinoma.
    Schutt AJ; Dalton RJ; Kovach JS; Moertel CG; O'Connell MJ
    Cancer Treat Rep; 1983 Jun; 67(6):593-4. PubMed ID: 6861166
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.
    Lawton JO; Giles GR; Hall J; MacAdam A; Hall R; Matheson T; Bird G
    Cancer Treat Rep; 1981; 65(1-2):13-15. PubMed ID: 6452945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
    Carroll DS; Kemeny NE; Gralla RJ
    Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II evaluation of vindesine in patients with advanced colorectal carcinoma.
    Carroll DS; Gralla RJ; Kemeny NE
    Cancer Treat Rep; 1979; 63(11-12):2097-8. PubMed ID: 526944
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of advanced adenocarcinoma of the kidney with mitolactol: a Southeastern Cancer Study Group Trial.
    Brubaker LH; Nelson MO; Birch R; Williams S
    Cancer Treat Rep; 1986 Feb; 70(2):305-6. PubMed ID: 3948194
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II trial of 5-fluorouracil plus melphalan in colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Mar; 62(3):461-2. PubMed ID: 348317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.